[1]
“Ribavirin free direct-acting antivirals in adolescents with hepatitis C and thalassemia”, J Fatima Jinnah Med Univ, vol. 12, no. 3, Feb. 2019, Accessed: Apr. 10, 2026. [Online]. Available: https://jfjmu.com/index.php/ojs/article/view/331